These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22178107)

  • 1. Limitations of compensated Jaffe creatinine assays in cirrhotic patients.
    Kuster N; Bargnoux AS; Pageaux GP; Cristol JP
    Clin Biochem; 2012 Mar; 45(4-5):320-5. PubMed ID: 22178107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays?
    Vickery S; Stevens PE; Dalton RN; van Lente F; Lamb EJ
    Nephrol Dial Transplant; 2006 Sep; 21(9):2439-45. PubMed ID: 16720592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score.
    Francoz C; Prié D; Abdelrazek W; Moreau R; Mandot A; Belghiti J; Valla D; Durand F
    Liver Transpl; 2010 Oct; 16(10):1169-77. PubMed ID: 20879015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
    Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
    Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?
    Finkenstedt A; Dorn L; Edlinger M; Prokop W; Risch L; Griesmacher A; Graziadei I; Vogel W; Zoller H
    Liver Int; 2012 Sep; 32(8):1211-6. PubMed ID: 22380485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome.
    Barakat M; Khalil M
    Arab J Gastroenterol; 2011 Sep; 12(3):131-5. PubMed ID: 22055590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing.
    Huang SH; Macnab JJ; Sontrop JM; Filler G; Gallo K; Lindsay RM; Clark WF
    Transl Res; 2011 Jun; 157(6):357-67. PubMed ID: 21575920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.
    Seo YS; Jung ES; An H; Kim JH; Jung YK; Kim JH; Yim HJ; Yeon JE; Byun KS; Kim CD; Ryu HS; Um SH
    Liver Int; 2009 Nov; 29(10):1521-7. PubMed ID: 19725889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly.
    Bevc S; Hojs R; Ekart R; Gorenjak M; Puklavec L
    Ther Apher Dial; 2011 Jun; 15(3):261-8. PubMed ID: 21624073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients.
    Pöge U; Gerhardt T; Stoffel-Wagner B; Klehr HU; Sauerbruch T; Woitas RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):660-4. PubMed ID: 16326735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
    Sterner G; Björk J; Carlson J; Grubb A; Nyman U
    Scand J Urol Nephrol; 2009; 43(3):242-9. PubMed ID: 19291590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney function estimating equations in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Int J Clin Pract; 2011 Apr; 65(4):458-64. PubMed ID: 21401834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the type of creatinine assay affect creatinine clearance determination?
    Hoste L; Martens F; Cooreman S; Doubel P; Pottel H
    Scand J Clin Lab Invest; 2014 Aug; 74(5):392-8. PubMed ID: 24779612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children.
    Neuman G; Nulman I; Adeli K; Koren G; Colantonio DA; Helldén A
    J Clin Pharmacol; 2014 Jul; 54(7):785-91. PubMed ID: 24596064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease.
    Rombach SM; Baas MC; ten Berge IJ; Krediet RT; Bemelman FJ; Hollak CE
    Nephrol Dial Transplant; 2010 Aug; 25(8):2549-56. PubMed ID: 20215390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care--an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates.
    Risch L; Saely CH; Neyer U; Hoefle G; Gouya G; Zerlauth M; Risch GM; Risch M; Drexel H
    Clin Chim Acta; 2007 Mar; 378(1-2):71-7. PubMed ID: 17157286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation?
    Huo SC; Huo TI; Lin HC; Chi CW; Lee PC; Tseng FW; Lee SD
    Transplantation; 2007 Dec; 84(11):1406-12. PubMed ID: 18091516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.
    Cholongitas E; Shusang V; Marelli L; Nair D; Thomas M; Patch D; Burns A; Sweny P; Burroughs AK
    Aliment Pharmacol Ther; 2007 Oct; 26(7):969-78. PubMed ID: 17877504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Model for End-Stage Liver Disease score: an independent prognostic factor of mortality in injured cirrhotic patients.
    Inaba K; Barmparas G; Resnick S; Browder T; Chan LS; Lam L; Talving P; Demetriades D
    Arch Surg; 2011 Sep; 146(9):1074-8. PubMed ID: 21576598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.